These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34581019)

  • 81. Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study.
    Pili B; Bourgaux C; Amenitsch H; Keller G; Lepêtre-Mouelhi S; Desmaële D; Couvreur P; Ollivon M
    Biochim Biophys Acta; 2010 Aug; 1798(8):1522-32. PubMed ID: 20435013
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Cisplatin, 5-fluorouracil, Irinotecan, and Gemcitabine Treatment in Resistant 2D and 3D Model Triple Negative Breast Cancer Cell Line: ABCG2 Expression Data.
    Ata FK; Yalcin S
    Anticancer Agents Med Chem; 2022; 22(2):371-377. PubMed ID: 34315389
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier.
    Pooja D; Panyaram S; Kulhari H; Reddy B; Rachamalla SS; Sistla R
    Int J Biol Macromol; 2015 Sep; 80():48-56. PubMed ID: 26093321
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery.
    Parsian M; Mutlu P; Yalcin S; Gunduz U
    Anticancer Agents Med Chem; 2020; 20(10):1233-1240. PubMed ID: 32156242
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.
    Chen Z; Zheng Y; Shi Y; Cui Z
    Int J Nanomedicine; 2018; 13():319-336. PubMed ID: 29391792
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.
    Zhou Y; Zhao RH; Tseng KF; Li KP; Lu ZG; Liu Y; Han K; Gan ZH; Lin SC; Hu HY; Min DL
    Acta Pharmacol Sin; 2016 Apr; 37(4):519-29. PubMed ID: 26924291
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Controlled drug release from polyelectrolyte-drug conjugate nanoparticles.
    Catarata R; Azim N; Bhattacharya S; Zhai L
    J Mater Chem B; 2020 Apr; 8(14):2887-2894. PubMed ID: 32191246
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
    Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
    Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In vitro and in vivo anticancer effects of two quinoline-platinum(II) complexes on human osteosarcoma models.
    Ruiz MC; Resasco A; Di Virgilio AL; Ayala M; Cavaco I; Cabrera S; Aleman J; León IE
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):681-692. PubMed ID: 30661096
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cytotoxic effects of C-glycosides in HOS and HeLa cell lines.
    Sanhueza CA; Mayato C; Machín RP; Padrón JM; Dorta RL; Vázquez JT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3676-81. PubMed ID: 17482817
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Gemcitabine with or without docetaxel and resection for recurrent osteosarcoma: the experience at Children's Memorial Hospital.
    Gosiengfiao Y; Reichek J; Woodman J; Ben-Ami T; Walterhouse D
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):e63-5. PubMed ID: 22217487
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Exploring the Anti-Cancer Potential of Hispidin: A Comprehensive in Silico and in Vitro Study on Human Osteosarcoma Saos2 Cells.
    Benarous K; Serseg T; Mermer A; Tahmasebifar A; Boulebd H; Linani A
    Chem Biodivers; 2024 May; 21(5):e202301833. PubMed ID: 38456582
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
    Bergman AM; Adema AD; Balzarini J; Bruheim S; Fichtner I; Noordhuis P; Fodstad O; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
    Invest New Drugs; 2011 Jun; 29(3):456-66. PubMed ID: 20066470
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment.
    Kushwah V; Agrawal AK; Dora CP; Mallinson D; Lamprou DA; Gupta RC; Jain S
    Pharm Res; 2017 Nov; 34(11):2295-2311. PubMed ID: 28795274
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-κB signal pathways.
    Wang Y; Wang S; Liu J; Lu Y; Li D
    Chem Biol Interact; 2018 Jun; 290():44-51. PubMed ID: 29782821
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In vitro cytotoxicity screening to identify novel anti-osteosarcoma therapeutics targeting pyruvate dehydrogenase kinase 2.
    Cao W; Wang Z; Han X; Liu J; Wang W
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126665. PubMed ID: 31495556
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs.
    Rodriguez CO; Crabbs TA; Wilson DW; Cannan VA; Skorupski KA; Gordon N; Koshkina N; Kleinerman E; Anderson PM
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):197-206. PubMed ID: 19803732
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.
    Lee JA; Paik EK; Seo J; Kim DH; Lim JS; Yoo JY; Kim MS
    Jpn J Clin Oncol; 2016 Feb; 46(2):138-43. PubMed ID: 26685322
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nudol, a phenanthrene derivative from
    Zhang Y; Zhang Q; Xin W; Liu N; Zhang H
    Drug Des Devel Ther; 2019; 13():2591-2601. PubMed ID: 31551653
    [No Abstract]   [Full Text] [Related]  

  • 100. Cytotoxic Effects of Castalin Nanoparticles Against Osteosarcoma.
    Zhang S; Ren H; Sun HT; Cao S
    Appl Biochem Biotechnol; 2023 Sep; 195(9):5355-5364. PubMed ID: 35226253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.